Table 1 The characteristics of patients with NAFLD and healthy controls.

From: Comprehensive profiling of serum microRNAs in normal and non-alcoholic fatty liver disease (NAFLD) patients

 

Reference range

NAFLD

No-NAFLD

p

n

 

3

3

 

Age (years)

 

12. 1 ± 0. 53

11. 9 ± 1. 79

0. 846

Hight(cm)

 

155. 7 ± 10. 02

156. 2 ± 5. 74

0. 94

Weight(Kg)

 

77. 0 ± 15. 87

69. 33 ± 3. 06

0. 477

BMI(Kg/m2)

 

31. 5 ± 3. 06

28. 38 ± 0. 75

0. 158

Waist circumference(cm)

 

99. 0 ± 9. 54

87. 67 ± 2. 52

0. 117

Hips circumference(cm)

 

101. 3 ± 8. 08

100. 33 ± 0. 58

0. 841

SBP

 

122. 3 ± 30. 4

115. 6 ± 4. 6

0. 700

DBP

 

65. 3 ± 11. 6

62. 6 ± 6. 1

0. 742

AST((U/L)

< 60

112. 3 ± 71. 45

18. 3 ± 3. 51

0. 085

ALT((U/L)

< 50

61. 3 ± 33. 95

23. 0 ± 4. 58

0. 125

TG (mmol/L)

< 1. 7

1. 25 ± 0. 10

1. 19 ± 0. 65

0. 876

CHO (mmol/L)

< 5. 7

5. 16 ± 0. 71

4. 62 ± 1. 09

0. 508

HLD-C (mmol/L)

> 1. 04

1. 23 ± 0. 04

1. 35 ± 0. 07

0. 058

UA

 

372. 00 ± 72. 19

384. 33 ± 114. 12

0. 882

Apo A

 

61. 33 ± 10. 69

114. 00 ± 44. 98

0. 120

FBG

 

5. 37 ± 0. 21

5. 43 ± 0. 25

0. 742

INS

 

22. 17 ± 7. 93

15. 33 ± 5. 87

0. 297

HOMA-IR

 

5. 34 ± 2. 13

3. 66 ± 1. 24

0. 304

  1. BMI body mass index, SBP Systolic blood pressure, DBP Diastolic blood pressure, UA Uric acid, Apo A Apolipoprotein A, TG triglyceride, CHO cholesterol, HLD-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, FBG Fasting blood glucose, INS Fasting insulin.
Back to article page